• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[全盆腔脏器切除术的适应症及随访]

[Indications and follow-up of total pelvic exenteration].

作者信息

Aleksic M, Hennes N, Schmitz-Dräger B J, Ulrich B

机构信息

Chirurgische Klinik, Krankenhaus Gerresheim, Kliniken der Landeshauptstadt Düsseldorf.

出版信息

Chirurg. 1998 Apr;69(4):450-4. doi: 10.1007/s001040050437.

DOI:10.1007/s001040050437
PMID:9612632
Abstract

From 1988 to 1996 we performed 18 total pelvic exenterations in patients with an average age of 59.8 years who could be followed up for a mean 29.8 months. In 10 cases a recurrent tumor of the pelvic viscera and 7 times a primary carcinoma of the rectum, bladder or prostate were treated. In 1 patient a radiogenic fistula led to this operation. Intestinal continuity could be reconstructed in 7 cases. Following cystectomy, urinary diversion was accomplished in half of the cases by an ileal conduit. Due to septic multiorgan failure 2 patients died postoperatively (hospital mortality rate 11%). In 82% a complete resection (R0) was possible. Subsequently 5 patients (29%) developed tumor recurrence. Distant metastases were observed in 3 patients, 8-9 months after surgery. So far 10 further patients have died. Their mean survival time was 28.9 months (range 5-99 months). The remaining 6 patients are still alive between 22 and 36 months postoperatively. Despite the extent of this kind of major surgery, which also requires multidisciplinary cooperation, and the psychosocial problems resulting from two permanent stomas, total pelvic exenteration should be regarded as an adequate alternative in the treatment plan in selected patients with locally advanced or recurrent pelvic disease.

摘要

1988年至1996年期间,我们对平均年龄为59.8岁的患者进行了18例全盆腔脏器切除术,这些患者的平均随访时间为29.8个月。其中10例为盆腔脏器复发肿瘤,7例为直肠、膀胱或前列腺原发性癌。1例患者因放射性瘘管而接受此手术。7例患者重建了肠道连续性。膀胱切除术后,半数患者通过回肠造口术进行尿流改道。由于感染性多器官功能衰竭,2例患者术后死亡(医院死亡率11%)。82%的患者实现了根治性切除(R0)。随后,5例患者(29%)出现肿瘤复发。3例患者在术后8 - 9个月出现远处转移。到目前为止,又有10例患者死亡。他们的平均生存时间为28.9个月(范围为5 - 99个月)。其余6例患者术后22至36个月仍存活。尽管这类大手术范围广,还需要多学科合作,且存在两个永久性造口带来的心理社会问题,但对于局部晚期或复发性盆腔疾病的特定患者,全盆腔脏器切除术仍应被视为治疗方案中的一种合适选择。

相似文献

1
[Indications and follow-up of total pelvic exenteration].[全盆腔脏器切除术的适应症及随访]
Chirurg. 1998 Apr;69(4):450-4. doi: 10.1007/s001040050437.
2
[Pelvic exenteration--indications, radical nature and follow-up demonstrated with 33 clinical cases].[盆腔脏器清除术——33例临床病例显示的适应证、根治性及随访情况]
Langenbecks Arch Chir Suppl Kongressbd. 1997;114:1096-7.
3
Total pelvic exenteration for primary and recurrent malignancies.原发性和复发性恶性肿瘤的全盆腔脏器切除术
World J Surg. 2009 Jul;33(7):1502-8. doi: 10.1007/s00268-009-0066-7.
4
[Quality of life after extensive pelvic surgery].[广泛盆腔手术后的生活质量]
Rozhl Chir. 2016 Fall;95(9):358-462.
5
Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.盆腔廓清术治疗晚期非直肠盆腔恶性肿瘤。
Ann Surg. 2019 Nov;270(5):899-905. doi: 10.1097/SLA.0000000000003533.
6
Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic neoplasia.全盆腔脏器切除术用于治疗晚期原发性或复发性盆腔肿瘤。
Cir Esp. 2015 Mar;93(3):174-80. doi: 10.1016/j.ciresp.2014.07.009. Epub 2014 Nov 22.
7
Retrospective review of pelvic malignancies undergoing total pelvic exenteration.盆腔恶性肿瘤全盆腔切除术的回顾性研究。
World J Surg Oncol. 2012 Jun 15;10:110. doi: 10.1186/1477-7819-10-110.
8
[Urologic reconstruction within the scope of interdisciplinary pelvic exenteration for treatment of invasive tumors of the pelvis].
Langenbecks Arch Chir Suppl Kongressbd. 1998;115:1497-8.
9
Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.全盆腔脏器切除术:对局部复发性前列腺癌患者会阴部疼痛的有效缓解
J Urol. 2003 Nov;170(5):1868-71. doi: 10.1097/01.ju.0000091656.94825.90.
10
Management of advanced pelvic cancer by exenteration.盆腔晚期癌的盆腔脏器清除术治疗
Eur J Surg Oncol. 2003 Nov;29(9):743-6. doi: 10.1016/j.ejso.2003.08.008.